Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Bojesen SE., Pooley KA., Johnatty SE., Beesley J., Michailidou K., Tyrer JP., Edwards SL., Pickett HA., Shen HC., Smart CE., Hillman KM., Mai PL., Lawrenson K., Stutz MD., Lu Y., Karevan R., Woods N., Johnston RL., French JD., Chen X., Weischer M., Nielsen SF., Maranian MJ., Ghoussaini M., Ahmed S., Baynes C., Bolla MK., Wang Q., Dennis J., McGuffog L., Barrowdale D., Lee A., Healey S., Lush M., Tessier DC., Vincent D., Bacot F., Australian Cancer Study None., Australian Ovarian Cancer Study None., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) None., Gene Environment Interaction and Breast Cancer (GENICA) None., Swedish Breast Cancer Study (SWE-BRCA) None., Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) None., Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) None., Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) None., Vergote I., Lambrechts S., Despierre E., Risch HA., González-Neira A., Rossing MA., Pita G., Doherty JA., Alvarez N., Larson MC., Fridley BL., Schoof N., Chang-Claude J., Cicek MS., Peto J., Kalli KR., Broeks A., Armasu SM., Schmidt MK., Braaf LM., Winterhoff B., Nevanlinna H., Konecny GE., Lambrechts D., Rogmann L., Guénel P., Teoman A., Milne RL., Garcia JJ., Cox A., Shridhar V., Burwinkel B., Marme F., Hein R., Sawyer EJ., Haiman CA., Wang-Gohrke S., Andrulis IL., Moysich KB., Hopper JL., Odunsi K., Lindblom A., Giles GG., Brenner H., Simard J., Lurie G., Fasching PA., Carney ME., Radice P., Wilkens LR., Swerdlow A., Goodman MT., Brauch H., Garcia-Closas M., Hillemanns P., Winqvist R., Dürst M., Devilee P., Runnebaum I., Jakubowska A., Lubinski J., Mannermaa A., Butzow R., Bogdanova NV., Dörk T., Pelttari LM., Zheng W., Leminen A., Anton-Culver H., Bunker CH., Kristensen V., Ness RB., Muir K., Edwards R., Meindl A., Heitz F., Matsuo K., du Bois A., Wu AH., Harter P., Teo S-H., Schwaab I., Shu X-O., Blot W., Hosono S., Kang D., Nakanishi T., Hartman M., Yatabe Y., Hamann U., Karlan BY., Sangrajrang S., Kjaer SK., Gaborieau V., Jensen A., Eccles D., Høgdall E., Shen C-Y., Brown J., Woo YL., Shah M., Azmi MAN., Luben R., Omar SZ., Czene K., Vierkant RA., Nordestgaard BG., Flyger H., Vachon C., Olson JE., Wang X., Levine DA., Rudolph A., Weber RP., Flesch-Janys D., Iversen E., Nickels S., Schildkraut JM., Silva IDS., Cramer DW., Gibson L., Terry KL., Fletcher O., Vitonis AF., van der Schoot CE., Poole EM., Hogervorst FBL., Tworoger SS., Liu J., Bandera EV., Li J., Olson SH., Humphreys K., Orlow I., Blomqvist C., Rodriguez-Rodriguez L., Aittomäki K., Salvesen HB., Muranen TA., Wik E., Brouwers B., Krakstad C., Wauters E., Halle MK., Wildiers H., Kiemeney LA., Mulot C., Aben KK., Laurent-Puig P., Altena AM., Truong T., Massuger LFAG., Benitez J., Pejovic T., Perez JIA., Hoatlin M., Zamora MP., Cook LS., Balasubramanian SP., Kelemen LE., Schneeweiss A., Le ND., Sohn C., Brooks-Wilson A., Tomlinson I., Kerin MJ., Miller N., Cybulski C., Henderson BE., Menkiszak J., Schumacher F., Wentzensen N., Le Marchand L., Yang HP., Mulligan AM., Glendon G., Engelholm SA., Knight JA., Høgdall CK., Apicella C., Gore M., Tsimiklis H., Song H., Southey MC., Jager A., den Ouweland AMW., Brown R., Martens JWM., Flanagan JM., Kriege M., Paul J., Margolin S., Siddiqui N., Severi G., Whittemore AS., Baglietto L., McGuire V., Stegmaier C., Sieh W., Müller H., Arndt V., Labrèche F., Gao Y-T., Goldberg MS., Yang G., Dumont M., McLaughlin JR., Hartmann A., Ekici AB., Beckmann MW., Phelan CM., Lux MP., Permuth-Wey J., Peissel B., Sellers TA., Ficarazzi F., Barile M., Ziogas A., Ashworth A., Gentry-Maharaj A., Jones M., Ramus SJ., Orr N., Menon U., Pearce CL., Brüning T., Pike MC., Ko Y-D., Lissowska J., Figueroa J., Kupryjanczyk J., Chanock SJ., Dansonka-Mieszkowska A., Jukkola-Vuorinen A., Rzepecka IK., Pylkäs K., Bidzinski M., Kauppila S., Hollestelle A., Seynaeve C., Tollenaar RAEM., Durda K., Jaworska K., Hartikainen JM., Kosma V-M., Kataja V., Antonenkova NN., Long J., Shrubsole M., Deming-Halverson S., Lophatananon A., Siriwanarangsan P., Stewart-Brown S., Ditsch N., Lichtner P., Schmutzler RK., Ito H., Iwata H., Tajima K., Tseng C-C., Stram DO., van den Berg D., Yip CH., Ikram MK., Teh Y-C., Cai H., Lu W., Signorello LB., Cai Q., Noh D-Y., Yoo K-Y., Miao H., Iau PT-C., Teo YY., McKay J., Shapiro C., Ademuyiwa F., Fountzilas G., Hsiung C-N., Yu J-C., Hou M-F., Healey CS., Luccarini C., Peock S., Stoppa-Lyonnet D., Peterlongo P., Rebbeck TR., Piedmonte M., Singer CF., Friedman E., Thomassen M., Offit K., Hansen TVO., Neuhausen SL., Szabo CI., Blanco I., Garber J., Narod SA., Weitzel JN., Montagna M., Olah E., Godwin AK., Yannoukakos D., Goldgar DE., Caldes T., Imyanitov EN., Tihomirova L., Arun BK., Campbell I., Mensenkamp AR., van Asperen CJ., van Roozendaal KEP., Meijers-Heijboer H., Collée JM., Oosterwijk JC., Hooning MJ., Rookus MA., van der Luijt RB., Os TAM., Evans DG., Frost D., Fineberg E., Barwell J., Walker L., Kennedy MJ., Platte R., Davidson R., Ellis SD., Cole T., Bressac-de Paillerets B., Buecher B., Damiola F., Faivre L., Frenay M., Sinilnikova OM., Caron O., Giraud S., Mazoyer S., Bonadona V., Caux-Moncoutier V., Toloczko-Grabarek A., Gronwald J., Byrski T., Spurdle AB., Bonanni B., Zaffaroni D., Giannini G., Bernard L., Dolcetti R., Manoukian S., Arnold N., Engel C., Deissler H., Rhiem K., Niederacher D., Plendl H., Sutter C., Wappenschmidt B., Borg A., Melin B., Rantala J., Soller M., Nathanson KL., Domchek SM., Rodriguez GC., Salani R., Kaulich DG., Tea M-K., Paluch SS., Laitman Y., Skytte A-B., Kruse TA., Jensen UB., Robson M., Gerdes A-M., Ejlertsen B., Foretova L., Savage SA., Lester J., Soucy P., Kuchenbaecker KB., Olswold C., Cunningham JM., Slager S., Pankratz VS., Dicks E., Lakhani SR., Couch FJ., Hall P., Monteiro ANA., Gayther SA., Pharoah PDP., Reddel RR., Goode EL., Greene MH., Easton DF., Berchuck A., Antoniou AC., Chenevix-Trench G., Dunning AM.
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed ∼480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 × 10(-7)), lower risks for estrogen receptor (ER)-negative (P = 1.0 × 10(-8)) and BRCA1 mutation carrier (P = 1.1 × 10(-5)) breast cancers and altered promoter assay signal. The minor allele at the peak 2 SNP rs7705526 associates with longer telomeres (P = 2.3 × 10(-14)), higher risk of low-malignant-potential ovarian cancer (P = 1.3 × 10(-15)) and greater promoter activity. The minor alleles at the peak 3 SNPs rs10069690 and rs2242652 increase ER-negative (P = 1.2 × 10(-12)) and BRCA1 mutation carrier (P = 1.6 × 10(-14)) breast and invasive ovarian (P = 1.3 × 10(-11)) cancer risks but not via altered telomere length. The cancer risk alleles of rs2242652 and rs10069690, respectively, increase silencing and generate a truncated TERT splice variant.